PHARMARESEARCH BIO Co., Ltd. Logo

PHARMARESEARCH BIO Co., Ltd.

A global biopharma firm creating regenerative medicine, pharmaceuticals, devices, and cosmetics.

217950 | KO

Overview

Corporate Details

ISIN(s):
KR7217950005
LEI:
Country:
South Korea
Address:
강원도 강릉시 사임당로 641-3 -, 강릉시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PHARMARESEARCH BIO Co., Ltd. is a global biopharmaceutical company dedicated to the research, development, manufacturing, and marketing of innovative biological products. A key part of the PharmaResearch group, which specializes in regenerative medicine, the company focuses on creating advanced treatments to improve human health and quality of life. Its R&D pipeline explores novel therapies and biologicals, including toxin-based technologies, contributing to a diverse portfolio that spans pharmaceuticals, medical devices, and cosmetics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-20 00:00
Share Issue/Capital Change
전환청구권행사 (제3회차)
Korean 11.2 KB
2025-04-30 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.6 KB
2025-04-23 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-03-25 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.0 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 9.4 KB
2025-03-17 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.0 MB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.4 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 94.3 KB
2024-12-30 00:00
Regulatory News Service
[기재정정]신규시설투자등
Korean 10.7 KB
2024-12-16 00:00
Notice of Dividend Amount
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 5.6 KB
2024-12-16 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2024-11-26 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득 (제4회차)
Korean 8.9 KB
2024-10-29 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.5 KB
2024-10-22 00:00
Legal Proceedings Report
불성실공시법인미지정
Korean 4.6 KB
2024-10-14 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.9 KB

Automate Your Workflow. Get a real-time feed of all PHARMARESEARCH BIO Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PHARMARESEARCH BIO Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PHARMARESEARCH BIO Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Clinical-stage biopharma developing novel cancer drugs aiming for fewer side effects.
Japan
4575
Candel Therapeutics, Inc. Logo
Developing off-the-shelf viral immunotherapies to help the immune system fight solid tumors.
United States of America
CADL
Can-Fite BioPharma Ltd. Logo
Develops oral small-molecule drugs targeting A3AR for oncology and inflammatory diseases.
Israel
CANF
Cannovum Cannabis AG Logo
Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.
Germany
27N0
Canopy Growth Corp Logo
Produces diverse cannabis products for medical and recreational markets globally.
United States of America
CGC
Cantourage Group SE Logo
A European platform producing and distributing medical cannabis products to pharmacies.
Germany
HIGH
CAPRICOR THERAPEUTICS, INC. Logo
Develops cell and exosome-based therapeutics for rare diseases like Duchenne muscular dystrophy.
United States of America
CAPR
CAREGEN CO.,LTD. Logo
Develops patented peptides and growth factors for medical aesthetics, pharma, and anti-aging markets.
South Korea
214370
Caribou Biosciences, Inc. Logo
Uses CRISPR genome editing to create off-the-shelf CAR-T cell therapies for cancer.
United States of America
CRBU
Carisma Therapeutics Inc. Logo
Developing engineered macrophage (CAR-M) therapies for solid tumors and autoimmune diseases.
United States of America
CARM

Talk to a Data Expert

Have a question? We'll get back to you promptly.